Source: Eur Respir J 2010; 35: 418-425
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Fadini G. P., Avogaro A., Ferraccioli G., Agostini C.. Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J 2010; 35: 418-425

Member's Comments

No comment yet.

Related content which might interest you: Plasticity of vascular progenitor cells: implications in pulmonary vascular remodeling in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 803s Year: 2006 Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Source: Eur Respir J 2010; 36: 1232-1235 Year: 2010 Role of progenitor cells in lung vascular repair: A novel approach for the treatment of pulmonary hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Plasticity of vascular progenitor cells: Implications in pulmonary vascular remodelling in COPD Source: Eur Respir Rev 2006; 15: 209-210 Year: 2006 Novel therapeutic perspectives in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 193-194 Year: 2003 Endothelial cells in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020 Year: 2021 Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021 Year: 2021 Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 New insights in pulmonary vascular biology and pathophysiology Source: Annual Congress 2006 - Physiological year in review Year: 2006 The emerging role of epigenetics in pulmonary hypertension Source: Eur Respir J 2016; 48: 903-917 Year: 2016 Endothelial progenitor cells in chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling? Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding Source: Eur Respir J 2013; 41: 462-468 Year: 2013 Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2015; 46: 431-443 Year: 2015 Targeting HIF2a-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension Source: Eur Respir J, 57 (3) 1902061; 10.1183/13993003.02061-2019 Year: 2021